Axiom Investors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4M Buy
+62,728
New +$12.1M 0.14% 65
2024
Q4
Sell
-222,254
Closed -$34.6M 137
2024
Q3
$34.6M Buy
+222,254
New +$35.9M 0.3% 43
2023
Q4
Sell
-5,300
Closed -$718K 137
2023
Q3
$718K Sell
5,300
-460,995
-99% -$63M 0.01% 121
2023
Q2
$66.7M Buy
466,295
+22,659
+5% +$3.33M 0.99% 30
2023
Q1
$61.6M Sell
443,636
-910,569
-67% -$123M 1.01% 31
2022
Q4
$184M Buy
1,354,205
+182,775
+16% +$22.9M 3.61% 6
2022
Q3
$128M Buy
1,171,430
+410,177
+54% +$52M 2.7% 11
2022
Q2
$101M Buy
+761,253
New +$99.9M 3.02% 10
2020
Q4
Sell
-666,035
Closed -$73M 128
2020
Q3
$73M Buy
666,035
+28,075
+4% +$3.12M 1.18% 22
2020
Q2
$67.5M Buy
637,960
+78,725
+14% +$8.13M 1.33% 22
2020
Q1
$50M Buy
559,235
+15,945
+3% +$1.5M 1.27% 20
2019
Q4
$54.2M Sell
543,290
-64,895
-11% -$6.11M 1.26% 22
2019
Q3
$54.2M Buy
608,185
+104,305
+21% +$9.04M 1.46% 23
2019
Q2
$41.6M Buy
503,880
+119,072
+31% +$9.34M 1.14% 29
2019
Q1
$31.1M Sell
384,808
-225
-0.1% -$17.7K 0.96% 29
2018
Q4
$29.2M Buy
+385,033
New +$30.1M 1.02% 29

Other funds holding AZN